Tag Archives: Sembiosys

A Calgary based biotech firm, SemBioSys has put one step ahead in the field of bio-technology by producing commercial quantities of human insulin from genetically modified safflower plants that would have a significant effect on the diabetes market. Andrew Baum, … Continue reading →